Practice English Speaking&Listening with: Eli Lilly’s Coronavirus Antibody Treatment Trial Halted | NBC Nightly News

Normal
(0)
Difficulty: 0

COME AS WAVES OF NEW COVID CASES SWEEP MUCH OF THE COUNTRY.

COVID CASES SWEEP MUCH OF THE COUNTRY. MIGUEL ALMAGUER HAS

OF THE COUNTRY. MIGUEL ALMAGUER HAS DETAILS.

MIGUEL ALMAGUER HAS DETAILS. >> Reporter: TONIGHT

DETAILS. >> Reporter: TONIGHT ELI LILLY, THE

>> Reporter: TONIGHT ELI LILLY, THE DRUGMAKER WORKING ON A

ELI LILLY, THE DRUGMAKER WORKING ON A COVID ANTIBODY

DRUGMAKER WORKING ON A COVID ANTIBODY TREATMENT FOR THOSE

COVID ANTIBODY TREATMENT FOR THOSE ALREADY INFECTED WITH

TREATMENT FOR THOSE ALREADY INFECTED WITH THE VIRUS, CONFIRMED

ALREADY INFECTED WITH THE VIRUS, CONFIRMED THEY ARE PAUSING A

THE VIRUS, CONFIRMED THEY ARE PAUSING A CLINICAL TRIAL OUT OF

THEY ARE PAUSING A CLINICAL TRIAL OUT OF AN ABUNDANCE OF

CLINICAL TRIAL OUT OF AN ABUNDANCE OF CAUTION AFTER NEW

AN ABUNDANCE OF CAUTION AFTER NEW POTENTIAL SAFETY

CAUTION AFTER NEW POTENTIAL SAFETY CONCERNS.

POTENTIAL SAFETY CONCERNS. KEN BEYERS TOOK PART

CONCERNS. KEN BEYERS TOOK PART IN ONE OF ELI LILLYS

KEN BEYERS TOOK PART IN ONE OF ELI LILLYS TRIALS THIS SUMMER.

IN ONE OF ELI LILLYS TRIALS THIS SUMMER. >> IM JUST LOOKING AT

TRIALS THIS SUMMER. >> IM JUST LOOKING AT THIS AS A SETBACK.

>> IM JUST LOOKING AT THIS AS A SETBACK. >> Reporter: WITH ELI

THIS AS A SETBACK. >> Reporter: WITH ELI LILLY CITING FEW

>> Reporter: WITH ELI LILLY CITING FEW DETAILS, THE MOVE

LILLY CITING FEW DETAILS, THE MOVE COMES JUST HOURS AFTER

DETAILS, THE MOVE COMES JUST HOURS AFTER JOHNSON & JOHNSON

COMES JUST HOURS AFTER JOHNSON & JOHNSON ANNOUNCED ITS ALSO

JOHNSON & JOHNSON ANNOUNCED ITS ALSO PAUSING THEIR STAGE 3

ANNOUNCED ITS ALSO PAUSING THEIR STAGE 3 VACCINE TRIAL BECAUSE

PAUSING THEIR STAGE 3 VACCINE TRIAL BECAUSE A PARTICIPANT SUFFERED

VACCINE TRIAL BECAUSE A PARTICIPANT SUFFERED AN UNEXPLAINED

A PARTICIPANT SUFFERED AN UNEXPLAINED ILLNESS.

AN UNEXPLAINED ILLNESS. JOHNSON & JOHNSON

ILLNESS. JOHNSON & JOHNSON JOINING ASTRAZENECA,

JOHNSON & JOHNSON JOINING ASTRAZENECA, BECOMING THE SECOND

JOINING ASTRAZENECA, BECOMING THE SECOND VACCINE CANDIDATE TO

BECOMING THE SECOND VACCINE CANDIDATE TO HIT A HURDLE OUT OF

VACCINE CANDIDATE TO HIT A HURDLE OUT OF THE FOUR IN FINAL

HIT A HURDLE OUT OF THE FOUR IN FINAL STRETCH OF

THE FOUR IN FINAL STRETCH OF DEVELOPMENT.

STRETCH OF DEVELOPMENT. >> WERE JUST LETTING

DEVELOPMENT. >> WERE JUST LETTING THE SCIENCE DICTATE

>> WERE JUST LETTING THE SCIENCE DICTATE HERE.

THE SCIENCE DICTATE HERE. WHAT IT SHOULD DO ALSO

HERE. WHAT IT SHOULD DO ALSO IS REASSURE THE PUBLIC

WHAT IT SHOULD DO ALSO IS REASSURE THE PUBLIC THAT EVERY SCIENTIFIC,

IS REASSURE THE PUBLIC THAT EVERY SCIENTIFIC, MEDICAL, AND ETHICAL

THAT EVERY SCIENTIFIC, MEDICAL, AND ETHICAL STANDARD IS BEING

MEDICAL, AND ETHICAL STANDARD IS BEING APPLIED HERE.

STANDARD IS BEING APPLIED HERE. >> Reporter: THE

APPLIED HERE. >> Reporter: THE VACCINE TRIAL

>> Reporter: THE VACCINE TRIAL SETBACKS, WHICH ARE

VACCINE TRIAL SETBACKS, WHICH ARE NOT UNCOMMON, COME AS

SETBACKS, WHICH ARE NOT UNCOMMON, COME AS A WAVE OF NEW COVID

NOT UNCOMMON, COME AS A WAVE OF NEW COVID CASES SPREAD ACROSS

A WAVE OF NEW COVID CASES SPREAD ACROSS THE NATION.

CASES SPREAD ACROSS THE NATION. 24TATES ARE NOW

THE NATION. 24TATES ARE NOW SEEING AT LEAST A 25%

24TATES ARE NOW SEEING AT LEAST A 25% RISE IN CASES.

SEEING AT LEAST A 25% RISE IN CASES. SOME DOCTORS SAY THIS

RISE IN CASES. SOME DOCTORS SAY THIS IS NO SURGE BUT

SOME DOCTORS SAY THIS IS NO SURGE BUT INSTEAD A TIDAL WAVE

IS NO SURGE BUT INSTEAD A TIDAL WAVE OF NEW INFECTIONS.

INSTEAD A TIDAL WAVE OF NEW INFECTIONS. >> SEEING SOME OF

OF NEW INFECTIONS. >> SEEING SOME OF THESE PEOPLE JUST NOT

>> SEEING SOME OF THESE PEOPLE JUST NOT PROGRESS, SEEING

THESE PEOPLE JUST NOT PROGRESS, SEEING MULTIPLE DEATHS,

PROGRESS, SEEING MULTIPLE DEATHS, MULTIPLE DAYS IN A

MULTIPLE DEATHS, MULTIPLE DAYS IN A ROW, ITS REALLY HARD.

MULTIPLE DAYS IN A ROW, ITS REALLY HARD. >> Reporter: WITH MORE

ROW, ITS REALLY HARD. >> Reporter: WITH MORE THAN A DOZEN STATES

>> Reporter: WITH MORE THAN A DOZEN STATES ALSO REPORTING A

THAN A DOZEN STATES ALSO REPORTING A RECORD NUMBER OF

ALSO REPORTING A RECORD NUMBER OF HOSPITALIZATIONS, NEW

RECORD NUMBER OF HOSPITALIZATIONS, NEW CASES AND NOW

HOSPITALIZATIONS, NEW CASES AND NOW FATALITIES ARE ALSO

CASES AND NOW FATALITIES ARE ALSO RESURFACING AT NURSING

FATALITIES ARE ALSO RESURFACING AT NURSING HOMES.

RESURFACING AT NURSING HOMES. IN RHODE ISLAND

HOMES. IN RHODE ISLAND OFFICIALS ARE

IN RHODE ISLAND OFFICIALS ARE IDENTIFYING A NEW

OFFICIALS ARE IDENTIFYING A NEW CLUSTER OF COVID

IDENTIFYING A NEW CLUSTER OF COVID INFECTIONS CONNECTED

CLUSTER OF COVID INFECTIONS CONNECTED TO CARPOOLS.

INFECTIONS CONNECTED TO CARPOOLS. IN SOME OF THE

TO CARPOOLS. IN SOME OF THE HARDEST-HIT REGIONS

IN SOME OF THE HARDEST-HIT REGIONS LIKE L.A. COUNTY

HARDEST-HIT REGIONS LIKE L.A. COUNTY HOSPITALS HAVE OPEN

LIKE L.A. COUNTY HOSPITALS HAVE OPEN ICU BEDS.

HOSPITALS HAVE OPEN ICU BEDS. THE QUESTION, HOW LONG

ICU BEDS. THE QUESTION, HOW LONG WILL IT LAST?

THE QUESTION, HOW LONG WILL IT LAST? DESPITE THE NEW SURGE

WILL IT LAST? DESPITE THE NEW SURGE IN INFECTIONS AND NOW

DESPITE THE NEW SURGE IN INFECTIONS AND NOW SETBACKS FOR COVID

IN INFECTIONS AND NOW SETBACKS FOR COVID TREATMENTS AND A

SETBACKS FOR COVID TREATMENTS AND A VACCINE, BYERS SAYS

TREATMENTS AND A VACCINE, BYERS SAYS THERES STILL REASON

VACCINE, BYERS SAYS THERES STILL REASON FOR HOPE.

THERES STILL REASON FOR HOPE. >> IT WOULD MAKE ME

FOR HOPE. >> IT WOULD MAKE ME ECSTASYTIC TO KNOW I WAS

>> IT WOULD MAKE ME ECSTASYTIC TO KNOW I WAS PART OF SOMETHING THAT

ECSTASYTIC TO KNOW I WAS PART OF SOMETHING THAT BECAME A TREATMENT.

PART OF SOMETHING THAT BECAME A TREATMENT. >> Reporter: TONIGHT

BECAME A TREATMENT. >> Reporter: TONIGHT THE ENDURING BATTLE

>> Reporter: TONIGHT THE ENDURING BATTLE AGAINST A GLOBAL PAN

THE ENDURING BATTLE AGAINST A GLOBAL PAN DEMOCRATIC AS IT

AGAINST A GLOBAL PAN DEMOCRATIC AS IT CONTINUES TO WAGE WAR

DEMOCRATIC AS IT CONTINUES TO WAGE WAR HERE AT HOME.

CONTINUES TO WAGE WAR HERE AT HOME. MIGUEL ALMAGUER, NBC

HERE AT HOME. MIGUEL ALMAGUER, NBC NEWS.

MIGUEL ALMAGUER, NBC NEWS. >>> LETS BRING IN OUR

NEWS. >>> LETS BRING IN OUR MEDICAL CORRESPONDENT

>>> LETS BRING IN OUR MEDICAL CORRESPONDENT DR. JOHN TORRES.

MEDICAL CORRESPONDENT DR. JOHN TORRES. JOHN, WE NOW HAVE TWO

DR. JOHN TORRES. JOHN, WE NOW HAVE TWO VACCINE TRIALS AND A

JOHN, WE NOW HAVE TWO VACCINE TRIALS AND A PROMISING TREATMENT

VACCINE TRIALS AND A PROMISING TREATMENT TRIAL ALL ON HOLD.

PROMISING TREATMENT TRIAL ALL ON HOLD. SHOULD PEOPLE BE

TRIAL ALL ON HOLD. SHOULD PEOPLE BE CONCERNED?

SHOULD PEOPLE BE CONCERNED? >> LESTER, PAUSING OR

CONCERNED? >> LESTER, PAUSING OR PUTTING A CLINICAL

>> LESTER, PAUSING OR PUTTING A CLINICAL TRIAL ON HOLD IS

PUTTING A CLINICAL TRIAL ON HOLD IS ACTUALLY QUITE COMMON.

TRIAL ON HOLD IS ACTUALLY QUITE COMMON. BUT USUALLY THESE

ACTUALLY QUITE COMMON. BUT USUALLY THESE PAUSES HAPPEN BEHIND

BUT USUALLY THESE PAUSES HAPPEN BEHIND THE SCENES.

PAUSES HAPPEN BEHIND THE SCENES. NOW, THOUGH, WITH THE

THE SCENES. NOW, THOUGH, WITH THE URGENCY IN THE

NOW, THOUGH, WITH THE URGENCY IN THE PANDEMIC, THERES MUCH

URGENCY IN THE PANDEMIC, THERES MUCH MORE PUBLIC ATTENTION

PANDEMIC, THERES MUCH MORE PUBLIC ATTENTION ON EVERY SINGLE STEP

MORE PUBLIC ATTENTION ON EVERY SINGLE STEP OF THE PROCESS.

ON EVERY SINGLE STEP OF THE PROCESS. THESE PAUSES ARE A

OF THE PROCESS. THESE PAUSES ARE A GOOD INDICATOR THAT

THESE PAUSES ARE A GOOD INDICATOR THAT COMPANIES ARE LOOKING

GOOD INDICATOR THAT COMPANIES ARE LOOKING SERIOUSLY AT NOT JUST

COMPANIES ARE LOOKING SERIOUSLY AT NOT JUST THE EFFECTIVENESS BUT

SERIOUSLY AT NOT JUST THE EFFECTIVENESS BUT ALSO THE SAFETY OF

THE EFFECTIVENESS BUT ALSO THE SAFETY OF THESE MEDICINES.

ALSO THE SAFETY OF THESE MEDICINES. NOW RESEARCHERS WILL

THESE MEDICINES. NOW RESEARCHERS WILL INVESTIGATE WHAT

The Description of Eli Lilly’s Coronavirus Antibody Treatment Trial Halted | NBC Nightly News